BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 23, 2026
Home » Blogs » BioWorld MedTech Perspectives » Twitter chats engage patients and experts

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Twitter chats engage patients and experts

June 3, 2014
By Amanda Pedersen

A DDW attendee stands in an inflatable colon tunnel on the exhibit floor in May.
A DDW attendee stands in an inflatable colon tunnel on the exhibit floor in May.

When I was first diagnosed with ulcerative colitis 15 years ago my instinct was to learn everything I could about the disease. Unfortunately, my doctor at that time discouraged me from educating myself. He handed me a pathetic little brochure that didn’t answer any of my questions and told me to stay away from the Internet. It seemed that to him, an uninformed patient was an ideal patient.

I never knew if that doctor was afraid my wee little layperson’s brain wouldn’t comprehend medical jargon, or if he just thought I would naively stumble upon misinformation. He also told me I was too young to have Crohn’s or colitis, collectively called inflammatory bowel disease (IBD), so perhaps he was the one who was misinformed.

Thankfully, times have changed. Patients today, regardless of the health condition they are faced with, are better informed than ever before. A plethora of consumer-targeted websites and mobile apps have launched in the name of patient education. Smart patients are taking responsibility for their own health and are actively seeking information to better manage their condition.

I witnessed a fantastic example of this trend last month during the annual Digestive Disease Week meeting in Chicago. I was impressed to see several IBD patients engaging with experts during DDW Twitter chats. The average patient doesn’t have the money or the credentials to attend medical meetings like DDW. But through Twitter, patients had front row access to experts and to the latest IBD research.

I’m certain the dialogue was equally beneficial for the doctors and researchers. Not only could these experts glean knowledge from each other, they were surely reminded of the impact their work has on actual patients.

In addition to IBD, the DDW Twitter chats explored trends in colorectal cancer screening, the role of the microbiomes in digestive diseases and the hepatitis C epidemic.

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing